Prof. Dr. Philippe Lefèbvre and Prof. Dr. Joachim Müller share their experiences leading the feasibility study on MED-EL’s Totally Implantable Cochlear Implant (TICI), breakthrough technology that integrates all cochlear implant components—audio processor, microphone, and battery—into one device under the skin.

There is growing evidence that cochlear implant recipients may benefit more from their devices if tonotopic mismatch is reduced. After providing an overview of recent research on tonotopic mismatch, this article explores how researchers and clinicians have been working to reduce tonotopic mismatch and improve hearing outcomes for MED-EL cochlear implant recipients.

Understanding music is a complex process. MED-EL's cochlear implant technology makes it possible for users to perceive and appreciate music.

Since 2006, each channel or pair of electrodes in MED-EL’s cochlear implants has had its own current source. These 12 channels with independent current sources allow each electrode pair to stimulate the cochlea with more flexibility. For instance, several different electrode pairs can stimulate different places in the cochlea at precisely the same time, which is often referred to as simultaneous or parallel stimulation.

Music promotes social connectedness and well-being. It plays an important part in people’s lives and remains an important factor in the lives of cochlear implant (CI) recipients.  “Music contributes to positive aging by providing ways for people to maintain positive self-esteem, feel competent, independent, and avoid feelings of isolation and loneliness,” and it can be